Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
about
Mucosal healing and deep remission: what does it mean?Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?Histologic scoring indices for evaluation of disease activity in ulcerative colitis.Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative ColitisLow Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic PerspectiveRaman spectroscopy of endoscopic colonic biopsies from patients with ulcerative colitis to identify mucosal inflammation and healing.Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice.Current and emerging maintenance therapies for ulcerative colitis.Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.Residual inflammation and ulcerative colitis in remission.Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative ColitisFecal calprotectin testing can identify ineffective colorectal cancer surveillance procedures in patients with longstanding colitis.Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease? Authors' reply.Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice.Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitisIndoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
P2860
Q26852447-13CC17C6-A75E-48A8-8BFE-E525BF6B6BADQ28072104-FF753050-5570-4A08-A2AB-B3B90E124835Q30234366-145F993D-6B3D-4B57-8D4B-735352966B1FQ35777883-C80684AA-658B-4E66-BE1C-CB060A6B68BAQ36604130-3556E10C-20D4-4444-A547-1707306EF7C8Q36912086-41AFF794-7480-47C2-A481-674AE168AD2EQ37288384-7BBFE20A-48E4-4DF6-BBFC-5D8D598450FDQ38197719-4850F89C-4339-4CCE-AEDC-B8D9C4BD0ADAQ38293774-C638BB49-CAF5-4532-A2EA-8533B42F2F8AQ38895063-0850132C-A0D8-4DB6-91F2-8B8F77FEFF05Q38950036-CC05A9F0-F04F-48A1-A7EC-8DBA57852980Q39064412-E81C7105-065C-4A18-AF09-B87AF168F526Q39356889-14546743-7F7F-4F4F-A635-A163D5D6520CQ39372195-9DA2C6ED-E802-4069-9E26-0BDFD4506369Q40038096-8F6AAE25-9A2A-45FF-8459-EA1035568121Q40555860-A529BCFC-7BA5-403D-89FE-88DEFD90A9C3Q40926333-48192BFF-231B-4E01-A7DD-4B7D507829EAQ41980696-5536F302-F04F-460E-88FB-3ED12D192B40Q44036386-F247D430-EFAA-456D-82D9-18411C581C03Q45340220-D987F457-8450-4E43-AF51-5F8CC106F73EQ46934021-5FE08566-6CDF-4E72-8DE4-A7EEC61BDC32Q48287325-D3F08E66-84ED-41AD-8008-C74F21DEE094Q50986872-4A22D416-4BDB-4E92-ADF0-594CA49A2108Q53451864-DBF308E3-169C-4E7D-BC87-AE7E4461CC3CQ54401840-CD3E913B-36AB-4657-B983-AB9956ECC8A9Q57815098-E2958F2A-1818-4F80-AE50-3CD2E3E56070Q58707093-86711C75-FDD1-470B-8B47-1D9C66654915
P2860
Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histologic markers of inflamma ...... colitis in clinical remission.
@en
Histologic markers of inflamma ...... colitis in clinical remission.
@nl
type
label
Histologic markers of inflamma ...... colitis in clinical remission.
@en
Histologic markers of inflamma ...... colitis in clinical remission.
@nl
prefLabel
Histologic markers of inflamma ...... colitis in clinical remission.
@en
Histologic markers of inflamma ...... colitis in clinical remission.
@nl
P2093
P2860
P1476
Histologic markers of inflamma ...... colitis in clinical remission.
@en
P2093
Adam S Cheifetz
Alan C Moss
Anne Gifford
Garrett O Lawlor
Jacqueline L Wolf
Jeffrey D Goldsmith
Kavinderjit S Nanda
Kenneth R Falchuk
Laura Rosenberg
Talia Zenlea
P2860
P304
P356
10.1016/J.CGH.2013.02.030
P407
P577
2013-04-13T00:00:00Z